UHC, Medtronic Use Value-Based Care to Boost Diabetes Management

Monday, July 16 2018

UHC, Medtronic Use Value-Based Care to Boost Diabetes Management

Population Health News UHC, Medtronic Use Value-Based Care to Boost Diabetes Management UnitedHealthcare and Medtronic’s value-based care model has cut preventable hospital admissions by nearly 30 percent and improved diabetes management. 16, 2018 - A value-based care partnership between UnitedHealthcare and Medtronic has reduced preventable hospital admissions by 27 percent, enhanced diabetes management, and cut healthcare costs.
First-year results, drawn from an analysis of over 6,000 UnitedHealthcare members using advanced insulin pump technologies and comprehensive support services offered by Medtronic, demonstrated a 27 percent decrease in avoidable hospital admissions compared to members using multiple daily injections of insulin (MDI).
"These positive results provide further evidence of the benefits of both automated insulin delivery and of value-based healthcare models," said Hooman Hakami, Executive Vice President and President of the Diabetes Group at Medtronic. Dig Deeper Clinical Analytics Aid Payers, Providers with Value-Based Care
"Through this unique partnership, Medtronic and UnitedHealthcare have demonstrated a commitment by both organizations to prioritize innovation that improves health outcomes and lowers healthcare costs."
UnitedHealthcare and Medtronic first announced an expanded relationship in 2016 that would offer plan members with diabetes access to automated insulin delivery.
Over the duration of the relationship, UnitedHealthcare and Medtronic will evaluate both quality of care and cost to provide more opportunities for plan patients to better manage their diabetes in a cost-effective manner.
UnitedHealthcare notes that more providers are engaging in the shift to value-based care, as the organization has increased its payments to physicians and hospitals involved in value-based arrangements to $65 billion in the last three years.
By the end of 2020, the payer expects that number to reach $75 billion.
UnitedHealthcare’s expanded partnership with Medtronic adds to its efforts to promote value-based care.
In 2016, UnitedHealthcare introduced NexusACO, a health plan option that offers members treatment through accountable care organizations.
“We are committed to the value-based care arrangement and we really believe that it is the future of delivering healthcare more affordably and providing the highest quality of care to our members,” Reed Bjergo, Vice President of Product Development at UnitedHealthcare, said at the time.
UnitedHealthcare reports that to date, NexusACO has reduced hospital admissions by 11 percent, emergency room visits by 8 percent, and readmissions by 7 percent, demonstrating the benefits of integrated, value-based care delivery. The organization projects that over 250,000 patients will be enrolled in NexusACO by the end of 2019.
UnitedHealthcare and Medtronic expect that their partnership will further improve diabetes management, cut healthcare costs, and support the transition to value-based care.
"These results show that patients with diabetes can benefit from using insulin pumps and comprehensive support services, thereby increasing the quality of the care they receive and reducing hospital admissions as well as costs," said Peter Pronovost, MD, Chief Medical Officer, UnitedHealthcare.
"The first-year results are encouraging, and we will monitor patients using Medtronic pump therapies to ensure we continue to see improved quality of care, fewer hospitalizations, and lower costs.” Tagged